Related Experiment Videos
Effects of liposteroid on skin lesions in autoimmune MRLlpr/lpr mice
M Aihara1, Y Aihara, Y Takahashi
1Department of Dermatology, Yokohama City University School of Medicine, Japan.
Abstract:
Dexamethasone palmitate (D-PAL) incorporated into lipid microspheres (D-PAL emulsion) is taken up by the reticuloendothelial system and by some inflammatory cells. Therefore, it has a stronger anti-inflammatory activity than free corticosteroids in vivo. To study the effect of D-PAL emulsion on systemic lupus erythematosus (SLE), we administered D-PAL emulsion to MRLlpr/lpr mice, an animal model for human SLE. The effect of D-PAL emulsion was compared with that of methylprednisolone (m-PSL), a water-soluble steroid. Percent survival was higher in the group treated with 0.25 mg of D-PAL emulsion intravenously once every 4 weeks than in those groups treated similarly with m-PSL or PBS control. Swelling of lymph nodes was frequent in the group treated with m-PSL or with PBS, while rarely observed in the group treated with D-PAL emulsion. Proteinuria was more frequent in the groups treated with m-PSL or PBS than in the group treated with D-PAL emulsion. Although the frequency of skin lesions was not different between these three groups, the control and m-PSL treated mice had severe skin lesions, such as hair loss of erythematous skin with scales and crusts at the nape, while D-PAL emulsion treated animals showed only facial alopecia without inflammatory skin changes. These data demonstrate that D-PAL emulsion was more effective than a corresponding dose of m-PSL on autoimmune prone mice. This suggests that intermittent administration of D-PAL emulsion may be effective in the treatment of human SLE.
Insights
Dexamethasone palmitate (D-PAL) emulsion showed superior efficacy compared to methylprednisolone (m-PSL) in treating lupus-prone mice. This novel formulation may offer a more effective treatment for systemic lupus erythematosus (SLE).
Area of Science:
- Immunology and Pharmacology
- Drug Delivery Systems
Background:
- Dexamethasone palmitate (D-PAL) emulsion targets the reticuloendothelial system and inflammatory cells, enhancing anti-inflammatory activity.
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease requiring effective therapeutic strategies.
Purpose of the Study:
- To evaluate the efficacy of D-PAL emulsion in MRLlpr/lpr mice, an established animal model for human SLE.
- To compare the therapeutic effects of D-PAL emulsion with methylprednisolone (m-PSL), a conventional corticosteroid.
Main Methods:
- MRLlpr/lpr mice were treated with D-PAL emulsion, m-PSL, or PBS (control) intravenously every 4 weeks.
- Key efficacy parameters assessed included survival rates, lymph node swelling, proteinuria, and skin lesion severity.
Main Results:
- D-PAL emulsion treatment resulted in significantly higher survival rates compared to m-PSL and PBS.
- Reduced incidence of lymph node swelling and proteinuria was observed in the D-PAL emulsion group.
- While skin lesion frequency was similar, D-PAL emulsion treated mice exhibited less severe skin manifestations.
Conclusions:
- Intermittent administration of D-PAL emulsion demonstrated superior therapeutic effects over m-PSL in a murine model of SLE.
- These findings suggest that D-PAL emulsion holds promise as a novel and effective treatment for human SLE.